ME01056B - Upotreba estradiolvalerata i dienogesta za oralno liječenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu - Google Patents

Upotreba estradiolvalerata i dienogesta za oralno liječenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu

Info

Publication number
ME01056B
ME01056B MEP-2009-171A MEP17109A ME01056B ME 01056 B ME01056 B ME 01056B ME P17109 A MEP17109 A ME P17109A ME 01056 B ME01056 B ME 01056B
Authority
ME
Montenegro
Prior art keywords
estradiolvalerate
dienogest
oral treatment
uterine bleeding
dysfunctional uterine
Prior art date
Application number
MEP-2009-171A
Other languages
English (en)
Inventor
Susan Zeun
Pol Boudes
Jan Endrikat
Angelo Secci
Holger Zimmermann
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35811580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01056(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of ME01056B publication Critical patent/ME01056B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
MEP-2009-171A 2005-10-13 2005-10-13 Upotreba estradiolvalerata i dienogesta za oralno liječenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu ME01056B (me)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05022324A EP1787649B1 (de) 2005-10-13 2005-10-13 Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption

Publications (1)

Publication Number Publication Date
ME01056B true ME01056B (me) 2012-10-20

Family

ID=35811580

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2009-171A ME01056B (me) 2005-10-13 2005-10-13 Upotreba estradiolvalerata i dienogesta za oralno liječenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu

Country Status (22)

Country Link
EP (2) EP1787649B1 (me)
JP (2) JP5735200B2 (me)
KR (2) KR101218872B1 (me)
CN (1) CN101312733A (me)
AR (1) AR056694A1 (me)
AT (2) ATE424828T1 (me)
CA (1) CA2623024C (me)
CL (1) CL2011000283A1 (me)
CY (2) CY1110321T1 (me)
DE (2) DE502005006837D1 (me)
DK (2) DK1787649T3 (me)
DO (1) DOP2006000221A (me)
ES (2) ES2322479T3 (me)
HR (1) HRP20090256T1 (me)
ME (1) ME01056B (me)
PE (2) PE20070555A1 (me)
PL (2) PL1787649T3 (me)
PT (2) PT1787649E (me)
SI (2) SI1787649T1 (me)
TW (2) TWI328453B (me)
UY (1) UY29861A1 (me)
WO (1) WO2007042296A1 (me)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ATE424828T1 (de) * 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE69724796T2 (de) * 1996-07-26 2004-07-01 Wyeth Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ATE424828T1 (de) * 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption

Also Published As

Publication number Publication date
EP1787649A1 (de) 2007-05-23
ES2360302T3 (es) 2011-06-02
DE502005006837D1 (de) 2009-04-23
CA2623024A1 (en) 2007-04-19
EP1787649B1 (de) 2009-03-11
SI1787649T1 (sl) 2009-08-31
PL1933843T3 (pl) 2011-06-30
CN101312733A (zh) 2008-11-26
TW200829255A (en) 2008-07-16
KR101218872B1 (ko) 2013-01-07
CL2011000283A1 (es) 2011-07-08
DE502006008853D1 (de) 2011-03-17
CA2623024C (en) 2012-03-06
TWI328453B (en) 2010-08-11
PE20100090A1 (es) 2010-03-12
WO2007042296A1 (de) 2007-04-19
PT1933843E (pt) 2011-04-29
DOP2006000221A (es) 2007-08-31
EP1933843B1 (de) 2011-02-02
ATE424828T1 (de) 2009-03-15
DK1787649T3 (da) 2009-06-02
EP1933843A1 (de) 2008-06-25
JP5735200B2 (ja) 2015-06-17
KR20100082389A (ko) 2010-07-16
UY29861A1 (es) 2007-05-31
JP2009511526A (ja) 2009-03-19
HRP20090256T1 (en) 2009-06-30
JP2013047269A (ja) 2013-03-07
CY1110321T1 (el) 2015-01-14
ATE497387T1 (de) 2011-02-15
KR20080065651A (ko) 2008-07-14
TW200731977A (en) 2007-09-01
DK1933843T3 (da) 2011-04-18
PT1787649E (pt) 2009-05-08
PE20070555A1 (es) 2007-07-12
CY1111406T1 (el) 2015-08-05
PL1787649T3 (pl) 2009-08-31
AR056694A1 (es) 2007-10-17
ES2322479T3 (es) 2009-06-22
SI1933843T1 (sl) 2011-06-30

Similar Documents

Publication Publication Date Title
HRP20160689T1 (hr) Selektivni modulatori progesterona za tretman uterinog krvarenja
ZA200710387B (en) Method and composition for use in preparation of a patient for surgery
GB0713746D0 (en) Device for reshaping hard and soft tissues of the jaw and dentition
EP1786424A4 (en) LONIDAMINE ANALOGUE AND ITS USE IN MALE CONTRACEPTION AND CANCER TREATMENT
PT1729656E (pt) Tesouras cirúrgicas ultrassónicas e almofada de tecido para as mesmas
IL191526A0 (en) Intrauterine ultrasound and method for use
PL1729656T3 (pl) Ultradźwiękowe nożyce chirurgiczne oraz nakładka ochronna tkanki do nich
IL185283A0 (en) Intrauterine fallopian tube occlusion device and method for use
EP1793745A4 (en) PROCESSES AND DEVICES FOR SEIZING AND ASSESSING FABRICS
EP1812102A4 (en) OKKLUSALSTENT AND USE METHOD THEREFOR
EP1855598A4 (en) METHOD AND DEVICES FOR ANCHORING IN SOFT TISSUE
EP1962698A4 (en) BONE ANCHOR FOR USE IN THE FIXING OF SOFT PARTS TO BONE
HK1117154A1 (en) Benzoquinazoline derivatives and their use in treating bone disorders
EP1895946A4 (en) IMPROVEMENTS FROM AND RELATED TO SURGICAL IMPLANTS
ZA200703446B (en) Use of an mTOR inhibitor in treatment of uterine leiomyoma
EP1998787A4 (en) RECOVERY AND REPAIR OF ORAL TISSUE
HK1109579A1 (en) Pharmaceutical composition comprising drospirenone and ethynylestradiol
EP1736173A4 (en) MEANS FOR THE TREATMENT OF TISSUE DAMAGE AND THERAPEUTIC PROCEDURE
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP1804676A4 (en) DEVICE FOR THE COMBINATION OF TISSUE AND ITS USE
SI1787649T1 (sl) Uporaba estradiolvalerata v kombinaciji z dienogestom za oralno terapijo disfunkcionalne maternične krvavitve skupaj z oralno kontracepcijo
EP1928247A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP2127681A4 (en) THERAPEUTIC AGENT AGAINST PARODONTAL DISEASES AND ALVEOLAR BONE LOSS THROUGH OPERATION
GB0717243D0 (en) Device for reshaping hard and soft tissues of the jaw and dentition
PL1764097T3 (pl) Sposoby i kompozycje kojące tkanki jamy ustnej i nosa